Thus, disturbance of STIM2-SOCE-CaMKII pathway contributes to synaptic loss and cognitive decline; conversely, upregulation of STIM2 expression levels or activation of synaptic neuronal SOCE pathway may yield therapeutic benefits for the treatment of AD and other age-related memory disorders (Figure 2). The gene discussed is STIM2; the disease is Alzheimer disease.